Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib in Metastatic Breast Cancer
NCT00101400Phase 2Completed
- Sponsor
- Bayer
- Start
- Feb 2004
- Primary completion
- Jan 2006
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of sorafenib in breast cancer, sponsored by Bayer. Started Feb 2004; status: completed.
02
Drugs
sorafenib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00101400.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00101400.